Increased angiogenesis is seen in susceptible mammary tissue in mouse models that overexpress Cox2 or Ccl2 [57, 58], and reduction of angiogenesis by genetic ablation of Cox2 significantly reduces MMTV-Erbb2/Neu-induced mammary tumor incidence [59]. The gene discussed is CCL2; the disease is breast cancer.